Astex Pharmaceuticals

Astex Pharmaceuticals is dedicated to the discovery and development of novel small molecule therapeuticsastex_logo_s_tag_otsuka-group_pms_v4 with a focus on oncology. Astex is developing a proprietary pipeline of novel therapies and has a number of partnered products being developed under collaborations with leading pharmaceutical companies. In October 2013, Astex was acquired by Otsuka Pharmaceutica
l Co. Ltd., Tokyo, Japan and operates as a wholly owned subsidiary. The Otsuka Group employs approximately 42,000 people globally, and its products are available in more than 80 countries worldwide.
For more information about Astex Pharmaceuticals, please visit http://www.astx.com